| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.81B | 72.63B | 63.53B | 59.54B | 51.54B | 49.79B |
| Gross Profit | 25.45B | 25.25B | 22.46B | 20.36B | 19.05B | 17.86B |
| EBITDA | 5.62B | 6.22B | 5.44B | 4.45B | 4.66B | 3.19B |
| Net Income | 2.04B | 2.17B | 2.01B | 1.68B | 1.84B | 1.36B |
Balance Sheet | ||||||
| Total Assets | 36.54B | 42.25B | 40.92B | 36.15B | 32.77B | 31.74B |
| Cash, Cash Equivalents and Short-Term Investments | 9.69B | 11.41B | 11.93B | 11.16B | 10.17B | 11.06B |
| Total Debt | 2.10B | 2.73B | 4.54B | 2.50B | 2.63B | 4.05B |
| Total Liabilities | 17.61B | 22.54B | 23.17B | 20.52B | 18.40B | 18.70B |
| Stockholders Equity | 16.75B | 17.54B | 16.50B | 14.65B | 13.45B | 12.44B |
Cash Flow | ||||||
| Free Cash Flow | 3.51B | 3.93B | 2.24B | 2.47B | 1.72B | 2.24B |
| Operating Cash Flow | 3.68B | 4.14B | 3.17B | 3.28B | 2.59B | 2.72B |
| Investing Cash Flow | -1.28B | -1.36B | -1.06B | -912.71M | -912.68M | -712.29M |
| Financing Cash Flow | -2.56B | -3.31B | -1.45B | -1.39B | -2.67B | -845.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥25.92B | 15.44 | ― | 2.18% | 9.56% | 30.03% | |
76 Outperform | ¥26.31B | 13.36 | ― | 3.93% | 11.90% | 69.40% | |
74 Outperform | ¥29.08B | 35.99 | ― | ― | 29.61% | 93.16% | |
72 Outperform | ¥26.27B | 9.67 | ― | 1.21% | 7.21% | 0.30% | |
68 Neutral | ¥28.74B | -28.94 | ― | 2.51% | 8.88% | 2.72% | |
68 Neutral | ¥27.59B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |